TGFBR2 and neoplasm: In contrast, our data in LUAD uncover a TGFβ1‐centric mechanism whereby Tgfbr2‐deficient tumour cells secrete TGFβ1 to induce PLVAP in tip‐like ECs, driving tumour invasiveness.